Advaxis to Provide 2013 Business Outlook  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Mar 6 Calls Today's Calls

Call Details Advaxis to Provide 2013 Business Outlook Scheduled to start Wed, Mar 6, 2013, 5:00 pm Eastern -- this event is ongoing now-- Listen to the ongoing live event audio stream About Advaxis Inc (OTC BB:ADXS.OB) Advaxis, Inc., a development stage biotechnology company, engages in the research and development of cancer-fighting techniques primarily in the United States. The company develops therapeutic cancer vaccines targeting cervical, head and neck, breast, prostate, and other cancers. Its products in development stage include ADXS11-001, a Phase I/II trial product for cervical intraepithelial neoplasia, cervical cancer, and head and neck cancer; ADXS31-142, a Phase I trial product for prostate cancer; and ADXS31-164, a Phase I trial product for breast cancer. The company has strategic collaboration agreement with Cobra Biomanufacturing PLC to manufacture cervical cancer vaccine. Advaxis, Inc. was founded in 2002 and is based in North Brunswick, New Jersey. More Info: Quote | Profile | Reports | Research | Insider | Financials